Table 2.
Demographics and disease characteristics of patients used for the elderly Adjuvant! Online evaluation analyses.
| Variable | Number | Percentage |
|---|---|---|
| Age (years) | ||
| 70–74 | 1944 | 66 |
| 75+ | 1023 | 34 |
| Sex | ||
| Male | 1569 | 53 |
| Female | 1398 | 47 |
| Tumor Stage | ||
| T1 | 83 | 3 |
| T2 | 441 | 15 |
| T3 | 2062 | 69 |
| T4 | 381 | 13 |
| Tumor Grade | ||
| Grade 1 | 278 | 9 |
| Grade 2 | 1950 | 66 |
| Grade 3+ | 739 | 25 |
| Positive Nodes | ||
| 1–3 | 1899 | 64 |
| 4–10 | 937 | 32 |
| >10 | 131 | 4 |
| Nodes Examined | ||
| 1–3 | 127 | 4 |
| 4–10 | 985 | 33 |
| >10 | 1855 | 63 |
| Adjuvant Therapy | ||
| 5-FU/LV | 1814 | 61 |
| + Oxaliplatin | 1153 | 39 |
| Trial Initiation Decade | ||
| 1980s | 211 | 7 |
| 1990s | 1349 | 45 |
| 2000s | 1407 | 47 |
| Total | 2,967 | 100 |